Publications by authors named "Ameya Chavan"

Claim this Profile
C
Cost-effectiveness of a multicancer early detection test in the US.
Anuraag R Kansal, Ali Tafazzoli, Alissa Shaul, Ameya Chavan, Weicheng Ye

Am J Manag Care· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan: A Patient-Level Simulation.
Ataru Igarashi, Mie Kasai Azuma, Quanwu Zhang, Weicheng Ye, Aditya Sardesai, Ameya Chavan

Neurol Ther· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated Societal Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
Amir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, Henri Folse, Ameya Chavan

Neurol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.
Amir Abbas Tahami Monfared, Weicheng Ye, Aditya Sardesai, Henri Folse, Ameya Chavan

Neurol Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer's Disease.
Amir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, Ameya Chavan, Kristen A Deger

Neurol Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Ali Tafazzoli, Scott D Ramsey, Alissa Shaul, Ameya Chavan, Weicheng Ye

Pharmacoeconomics· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential Economic Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
Amir Abbas Tahami Monfared, Ali Tafazzoli, Ameya Chavan, Weicheng Ye, Quanwu Zhang

Neurol Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
Amir Abbas Tahami Monfared, Ali Tafazzoli, Weicheng Ye, Ameya Chavan, Quanwu Zhang

Neurol Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia.
Michael L Ganz, Ameya Chavan, Rahul Dhanda, Michael Serbin, Charles Yonan

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling long-term health and economic implications of new treatment strategies for Parkinson's disease: an individual patient simulation study.
Conor Chandler, Henri Folse, Peter Gal, Ameya Chavan, Irina Proskorovsky

J Mark Access Health Policy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency Model of Cladribine Tablets Versus Infusion-Based Disease-Modifying Drugs for Patients with Relapsing-Remitting Multiple Sclerosis.
Ali Tafazzoli, Ameya Chavan, Gerard Harty, Jorgen Moller, Schiffon L Wong

Adv Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of N-substituted-3-chloro-2-azetidinones.
Ameya A Chavan, Nandini R Pai

Molecules· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis